Informed Girl
Informed SkinTranexamic Acid

Products

Tranexamic Acid

Tranexamic acid (TXA)

Emerging topical and oral treatment for melasma and post-inflammatory hyperpigmentation

HyperpigmentationDark Spots
In plain English

A brightening active that works by interrupting the signal that tells skin cells to produce excess melanin. Effective for melasma (the hormonal brown patches common in pregnancy or with oral contraceptives) and post-inflammatory hyperpigmentation. Available both as a topical serum (OTC, low risk) and as an oral prescription (more powerful, requires monitoring). One of the best-evidenced newer options for pigmentation in darker skin types.

Safe for skin types
Safe forAll Fitzpatrick types I–VI
Avoid ifNone related to Fitzpatrick type

Tranexamic acid inhibits plasmin-mediated melanocyte activation and is particularly beneficial for Fitzpatrick IV–VI, where melasma and post-inflammatory hyperpigmentation are more prevalent. It is one of the best-evidenced brightening agents for darker skin types because it lacks the irritation and atrophy risks associated with long-term hydroquinone use.

Common misconceptions
Myth

Tranexamic acid is the same as hydroquinone.

Reality

Different mechanism and safety profile. TXA has no reported skin atrophy risk or ochronosis risk associated with long-term hydroquinone use. The evidence quality for TXA is growing but hydroquinone has a larger historical evidence base.

Myth

All tranexamic acid products work the same way.

Reality

Topical and oral TXA have different pharmacokinetics and different evidence profiles. A 10% topical serum does not deliver the same systemic concentration as 250mg oral twice daily.

Quick Facts
DurationTopical: daily use, results in 8-12 weeks; oral: 3 months
Studies60+
FDA StatusOTC cosmetic ingredient (topical); Rx (oral, off-label for melasma)
Price$15-$80 serum (topical); $30-$60/month (oral Rx)

Should You Try This?

15107OUT OF 10

Probably okay to try

Questions to ask your doctor

  • Q1

    Am I a candidate for oral vs topical tranexamic acid given my melasma severity?

    Good answer

    A good answer assesses MASI score and explains when the oral form adds benefit over topical, typically for moderate-to-severe melasma that has not responded adequately to topical treatment.

  • Q2

    What is the recommended course length and what monitoring do you conduct?

    Good answer

    A good answer specifies typically 3 months for oral TXA, with awareness of any clotting risk factors and a clear rationale for the duration.

  • Q3

    Are there contraindications given my personal or family health history?

    Good answer

    A good answer screens for personal or family history of deep vein thrombosis, pulmonary embolism, or clotting disorders before prescribing oral TXA.

Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.

Researched by

Val Yermakova

Informed Girl · informedgirl.com

The Weekly Briefing

Stay informed

Every paper is individually reviewed and scored for study design, blinding, and funding independence. Educational content, not medical advice.

Subscribe for updates about the latest research. No spam.